Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

PHASE1CompletedINTERVENTIONAL
Enrollment

269

Participants

Timeline

Start Date

June 7, 2021

Primary Completion Date

March 10, 2025

Study Completion Date

March 10, 2025

Conditions
Non Small Cell Lung CancerCervical CancerSCCHNPancreatic CancerEsophageal SCCMetastatic Castration-resistant Prostate CancerTriple Negative Breast CancerHormone Receptor-positive Breast CancerEpithelial Ovarian CancerEndometrial CancerTissue Factor-Expressing Solid Tumors
Interventions
DRUG

XB002

IV administration of XB002

DRUG

Nivolumab

IV administration of Nivolumab

DRUG

Bevacizumab

IV administration of bevacizumab

Trial Locations (95)

1070

Exelixis Clinical Site#56, Brussels

1200

Exelixis Clinical Site #30, Brussels

1217

Exelixis Clinical Site#64, Madrid

2010

Exelixis Clinical Site #37, Darlinghurst

2065

Exelixis Clinical Site #35, Saint Leonards

2170

Exelixis Clinical Site #44, Liverpool

2228

Exelixis Clinical Site#75, Miranda

2650

Exelixis Clinical Site #47, Edegem

4000

Exelixis Clinical Site#66, Liège

6000

Exelixis Clinical Site#71, Charleroi

6009

Exelixis Clinical Site#70, Nedlands

6591

Exelixis Clinical Site#85, Seoul

8035

Exelixis Clinical Site#55, Barcelona

8908

Exelixis Clinical Site#82, Barcelona

9000

Exelixis Clinical Site #38, Ghent

10016

Exelixis Clinical Site #12, New York

11042

Exelixis Clinical Site#67, Lake Success

12206

Exelixis Clinical Site #23, Albany

13496

Exelixis Clinical Site#80, Seongnam-si

13620

Exelixis Clinical Site#74, Seongnam-si

14068

Exelixis Clinical Site#79, Anyang-si

16247

Exelixis Clinical Site#83, Suwon

20007

Exelixis Clinical Site #22, Washington D.C.

20089

Exelixis Clinical Site #34, Rozzano

20132

Exelixis Clinical Site#84, Milan

20141

Exelixis Clinical Site#62, Milan

21044

Exelixis Clinical Site #18, Columbia

21287

Exelixis Clinical Site #6, Baltimore

22903

Exelixis Clinical Site #9, Charlottesville

25198

Exelixis Clinical Site #31, Lleida

28027

Exelixis Clinical Site #17, Madrid

28040

Exelixis Clinical Site #33, Madrid

28050

Exelixis Clinical Site #42, Madrid

28223

Exelixis Clinical Site #13, Madrid

29010

Exelixis Clinical Site #46, Málaga

33000

Exelixis Clinical Site #45, Bordeaux

35042

Exelixis Clinical Site #50, Rennes

35294

Exelixis Clinical Site #48, Birmingham

37203

Exelixis Clinical Site #3, Nashville

43026

Exelixis Clinical Site #49, Hilliard

44106

Exelixis Clinical Site #15, Cleveland

44195

Exelixis Clinical Site #29, Cleveland

46010

Exelixis Clinical Site #43, Valencia

46026

Exelixis Clinical Site #51, Valencia

48202

Exelixis Clinical Site #19, Detroit

49201

Exelixis Clinical Site #10, Detroit

Exelixis Clinical Site#86, Pusan

50009

Exelixis Clinical Site#72, Zaragoza

50134

Exelixis Clinical Site#60, Florence

53100

Exelixis Clinical Site#61, Siena

58128

Exelixis Clinical Site#78, Hwasun

60126

Exelixis Clinical Site #54, Ancona

60637

Exelixis Clinical Site#93, Chicago

63110

Exelixis Clinical Site #5, St Louis

67200

Exelixis Clinical Site#63, Strasbourg

68130

Exelixis Clinical Site #11, Omaha

69310

Exelixis Clinical Site #41, Pierre-Bénite

69373

Exelixis Clinical Site#69, Lyon

72205

Exelixis Clinical Site#58, Little Rock

73104

Exelixis Clinical Site #4, Oklahoma City

75013

Exelixis Clinical Site#87, Paris

75246

Exelixis Clinical Site #32, Dallas

75390

Exelixis Clinical Site #14, Dallas

77030

Exelixis Clinical Site#92, Houston

78229

Exelixis Clinical Site #2, San Antonio

78705

Exelixis Clinical Site #24, Austin

78758

Exelixis Clinical Site #1, Austin

85704

Exelixis Clinical Site #20, Tucson

85719

Exelixis Clinical Site#95, Tucson

86000

Exelixis Clinical Site#68, Poitiers

90025

Exelixis Clinical Site #21, Los Angeles

90404

Exelixis Clinical Site #26, Los Angeles

92708

Exelixis Clinical Site#59, Fountain Valley

94805

Exelixis Clinical Site#53, Villejuif

06511

Exelixis Clinical Site #16, New Haven

02215

Exelixis Clinical Site #25, Boston

08816

Exelixis Clinical Site #8, East Brunswick

08903

Exelixis Clinical Site #7, New Brunswick

00144

Exelixis Clinical Site #40, Roma

00168

Exelixis Clinical Site#90, Roma

1066 CX

Exelixis Clinical Site#73, Amsterdam

3015 GD

Exelixis Clinical Site#76, Rotterdam

9713 GZ

Exelixis Clinical Site#65, Groningen

6229 HX

Exelixis Clinical Site #39, Maastricht

02841

Exelixis Clinical Site#77, Seoul

05505

Exelixis Clinical Site#94, Seoul

06351

Exelixis Clinical Site#81, Seoul

08023

Exelixis Clinical Site #27, Barcelona

08028

Exelixis Clinical Site #36, Barcelona

LE1 5WW

Exelixis Clinical Site#88, Leicester

SE1 9RT

Exelixis Clinical Site#89, London

CF14 2TL

Exelixis Clinical Site#91, Cardiff

G12 0YN

Exelixis Clinical Site #52, Glasgow

W1T 7HA

Exelixis Clinical Site#57, London

NE7 7DN

Exelixis Clinical Site #28, Newcastle upon Tyne

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Exelixis

INDUSTRY

NCT04925284 - Study of XB002 in Subjects With Solid Tumors (JEWEL-101) | Biotech Hunter | Biotech Hunter